Clinical Trial

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-10; most recent amendment 2025-07-03.
Status change: Not Yet Recruiting → Recruiting 2025-06-13
Trial Details
NCT Number NCT06926608
Lead Sponsor University of Rochester
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD), Hackensack Meridian Health
Conditions Smoking, Smoking Cessation, Physical Inactivity
Enrollment 408 participants
Start Date 2025-06-17
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-08